On July 4th Jermaine Jackson posted a link to a Globe ROB article and it gives a flavour of why RVX is missing out.

From the Globe ROB July 4th, 2020

When Ali Tehrani’s startup Zymeworks went public in 2017, he wanted to bring Canadian investors into the fold, pursuing dual listings on both the New York and Toronto stock exchanges. But last fall, Zymeworks delisted from the TSX to focus on the NYSE, where most of the trading happened. ‘The institutional money on Bay Street is just turned off by biotech,’ he says. His message to Canadian fund managers: ‘You’re missing out and you are going to keep missing out, and you’ll keep making excuses why it doesn’t make sense for you. But you’ll see more of us do this.’

Is this sour grapes or the reality that RVX faces on the TSX?

The impression I got is that RVX is simply not on investors radar and that without a NASDAQ our share price will never be optimized.

As always I've enjoyed the posts lately and got a kick out of the discussion of Don being a doctor. That discussion really had me laughing. If you have ever watched any of his presentations I think you would wonder whether he has any education at all. That being said, the ship is still afloat, for now.

GLTA

Toinv